Introduction: Specifi c inspiratory muscle training (IMT) has been shown to signifi cantly attenuate the fall in arterial oxygen saturation (S p O 2 ) during exhaustive exercise while breathing a hypoxic gas mixture of 14% oxygen. The aim of the current study was to assess the impact of IMT on resting S p O 2 over a range of altitudes in healthy individuals. Methods: Resting S p O 2 and the Borg Score were examined at altitudes of 0 or 400 m (0 -400 m; 0 -1312.3 ft), 1400 m, 4880 m, and 5550 m (4593 ft, 16,011 ft, and 18,209 ft ) in 14 military personnel who were part of a climbing expedition to the Nepali Himalaya. Volunteer participants were randomly assigned to either a control ( N 5 7) or IMT ( N 5 7) group: IMT consisted of 1 set of 30 breaths twice daily at 50% maximal inspiratory mouth pressure (MIP) for 4 wk prior to departure. Results: MIP was similar between groups pre-IMT but increased signifi cantly by 15% post-IMT. Baseline maximal expiratory mouth pressure was not different between groups. The Borg Score increased signifi cantly from 1400 m, but was not different between groups at any altitude. Resting S p O 2 declined signifi cantly at ascending altitudes in both groups and was similar between groups at altitudes of 0-400 m and 1400 m. However, at altitudes of 4880 m and 5550 m, S p O 2 was signifi cantly higher (6%) in the IMT group. Conclusion: IMT can attenuate the fall in resting S p O 2 , but only at altitudes of 4880 m and above. Conversely, IMT had no effect on resting levels of dyspnea as measured by the Borg Score.
H
YPOBARIC AND normobaric hypoxia both induce a number of acute and chronic physiological changes. One of the acute alterations is an increase in minute ventilation, which arises because the reduction in arterial oxygen partial pressure (P a O 2 ) stimulates peripheral chemoreceptors. Given the infl uence of P a O 2 on hemoglobin oxygen saturation (S a O 2 ), it is unsurprising that S a O 2 (or S p O 2 if estimated using pulse oximetry) declines during ascent from sea level to altitude ( 9 ) . However, the reduction in S a O 2 does not go uncompensated and the hyperventilatory response to hypoxia causes pH to increase ( 8 ) . This in turn promotes oxygen-hemoglobin binding in the lung and attenuates, although does not abolish, arterial desaturation ( 13 ) .
The prolonged alkalosis occurring at altitude is harmful and is counteracted (in part) by an increase in 2,3-diphosphoglycerate, which shifts the oxygen dissociation curve to the right ( 8 ) . Nevertheless, complete respiratory compensation does not occur ( 13 ) . As a result, a balance is sought between enhancing oxygen loading in the lung, promoting oxygen unloading at the tissue, and minimizing pH disturbances ( 9 ) .
The consequences of hypoxia on exercise performance have been examined extensively under normobaric hypoxic conditions. Studies have shown that breathing a gas mixture with a fractional inspired oxygen concentration (F I O 2 ) of 0.15 -0.13 can signifi cantly shorten exercise time to exhaustion ( 12 ) and reduce maximal force output of the quadriceps ( 1 ). These changes are associated with signifi cantly reduced exercising S p O 2 values to around 76 -82% ( 1 , 12 ) . In comparison, breathing a hyperoxic gas mixture (F I O 2 of 1.00), which preserves S a O 2 , can signifi cantly reduce quadricep muscle fatigue at a given exercise intensity at sea level ( 1 ) . Similarly, partial acclimatization to moderate altitude improves both S a O 2 and exercise tolerance ( 5 ) .
Inspiratory muscle training (IMT) has been shown to have a protective infl uence on exercising S p O 2 during normobaric hypoxic conditions [F I O 2 5 0.14, approximate altitude of 3050 m (10,006.6 ft)] by reducing the magnitude of arterial desaturation by approximately 5% ( 4 ). As a similar ' protective effect ' was not observed in resting S p O 2 post-IMT, one may postulate that the cardiopulmonary stress at rest was not severe enough for IMT to have a protective infl uence. If this was the case, IMT may exert a protective effect on resting S p O 2 when a threshold level or range of hypoxia (and hence altitude) is reached. Therefore, it was the intention of this study to test the hypothesis that at altitudes in excess of 3050 m, IMT would signifi cantly reduce the magnitude of arterial desaturation experienced at rest.
METHODS
The study protocol was approved in advance by the Biosciences Research Ethics Committee at the University of Portsmouth. Each subject provided written informed consent before participating. In total, 14 healthy service personnel from the British Armed Forces (12 men and 2 women) participated. All were part of an expedition to Mount Makalu in the Nepali Himalaya which took place in the summer of 2008. Subjects had no history of cardio-IMT, ALTITUDE, & S P o 2 -LOMAX vascular or respiratory diseases, had passed a military medical within the past 12 mo, and were experienced mountaineers. Mean and SD for age, body mass, and stature was 37 (±5) yr, 72 (±8) kg, and 1.70 (±0.20) m, respectively.
Experimental Design
Maximal inspiratory and expiratory mouth pressures (MIP and MEP, respectively) were determined in accordance with the American Thoracic Society/European Respiratory Society guidelines ( 2 ) on respiratory muscle testing. Following the determination of MIP and MEP (RPM Micro Medical, Rochester , UK), subjects were randomly assigned to either an IMT ( N 5 7) or control ( N 5 7) group. The IMT group undertook 4 wk of pressure-threshold IMT (POWERbreathe, HaB International, Southam, Warwickshire , UK) consisting of 1 set of 30 breaths at 30 repetitions maximum ( ; 50 -60% MIP), twice daily, 7 days per week. The load on the trainer was adjusted weekly by the subjects to account for their increasing inspiratory muscle strength ( 7 ) . The start date of the IMT was administered so that the fi nal IMT session fi nished, at most, 3 d before departing the UK.
S p O 2 (%) was assessed non-invasively using a pulse oximeter (Onyx 9500 fi nger probe, Nonin, Plymouth, MA) at sea level or 400 m [0-400 m (0 -1312 ft); day 1] and at altitudes of 1400 m (4593 ft; day 1), 4880 m (16,011 ft; day 16), and 5550 m (18,209 ft; day 20; two subjects reached this camp on day 24), which corresponded to expedition camps in the Nepali Himalaya. To standardize data collection S p O 2 was measured within 24 h of arrival at the camps and where possible at a similar time of day at each camp. Dyspnea was assessed at each camp using the Borg CR-10 scale. The number of subjects assessed at each altitude, along with barometric pressure (P B ; mmHg) and air temperature (°C) can be found in Table I .
Data Analyses
As parametric data assumptions were met (ShapiroWilks test), two-way repeated measures ANOVAs with between-subject effects (IMT vs. control) were used to assess S p O 2 , MIP, and dyspnea. Paired sample t -tests with Bonferonni adjustments were used to identify any signifi cant within-group differences and independent sample t -tests were used to identify differences between groups. Baseline MEP was assessed using an independent samples t -test. An alpha level of 0.05 was set as a priori for statistical signifi cance. Data are expressed as mean (SD). ( Fig. 1 ) . Dyspnea was similar between groups ( P 5 0.462) despite increasing signifi cantly as subjects ascended above 1400 m (dyspnea was identical at 0 -400 m and 1400 m with a Borg Score of 0 for both altitudes per group). Specifi cally, dyspnea at 4880 m [0.6 (0.6) and 1.1 (1.0), IMT and control, respectively] and 5550 m [1.8 (1.1) and 2.0 (1.1), IMT and control, respectively] was significantly different to every other altitude ( P , 0.05).
RESULTS
was 99 (0.5) and 99 (1.0) for control and IMT groups, respectively]. S p O 2 was 6% higher in the IMT group at altitudes of 4880 m ( P 5 0.001) and 5550 m ( P 5 0.050)
DISCUSSION
The main fi nding of the current study is that IMT, which increased inspiratory muscle strength by 15%, attenuated the fall in resting S p O 2 at altitudes of 4880 m and 5550 m by 6% ( Fig. 1 ) , but had no impact on the Borg Score. As respiratory comfort was well maintained at each altitude (Borg Scores did not rise above 2.0 6 1.0), the lack of difference between groups is not surprising and is consistent with previous reports that exhaustive exercise is required before hypoxia affects respiratory perception ( 4 , 12 ) .
The role of IMT in modulating physiological variables during exercise has been well documented. Improvements in time trial performance, enhanced recovery rates, reduced levels of blood lactate, and respiratory ( 4 ) and at rest in the current study are yet to be fully resolved. As Downey et al. ( 4 ) adopted a single acute bout of hypoxia and used an exercising model (although resting data was also reported), comparisons between their observations and those of the current study need to be made with caution. Nevertheless, the observed magnitude of resting arterial desaturation observed at altitudes of 4880 m and 5550 m in the current study (6%, see Fig. 1 ), was similar (5%) to that observed during submaximal hypoxic (F I O 2 of 0.14) exercise to exhaustion by Downey et al. ( 4 ) . Importantly, however, a protective effect was not observed at rest in the latter study or at altitudes of 1400 m and below in the current study ( Fig. 1 ) : this point will be returned to shortly. The reasons for Downey and colleagues ( 4 ) exercising observations are poorly understood, but are probably linked to alterations in pulmonary capillary red blood cell transit time, the ventilation-perfusion ratio, ventilation, and/or pulmonary diffusion capacity ( 3 ).
Specifi cally, Downey et al. ( 4 ) observed an increase in lung diffusing capacity of around 23% ( P , 0.05) post exhaustive submaximal exercise (5 min) and a reduction in exercise minute ventilation of approximately 24% ( P , 0.05) at a point when S p O 2 was around 4% higher ( P , 0.05) post-compared to pre-IMT. They suggested that a reduction in respiratory muscle work during exercise post-IMT led to a reduction in oxygen consumption and cardiac output. This in turn probably lengthened red blood cell transit time through the pulmonary capillary bed and hence S p O 2 increased ( 4 ). The fact that IMT failed to impact resting S p O 2 in their study but did in the present study may simply refl ect differences in resting cardiopulmonary stress. Given that the fall in resting S p O 2 was only attenuated at altitudes of 4880 and 5550 m in the current study, it is reasonable to assume that the resting cardiopulmonary stress would have been greater than that experienced by Downey and colleagues' ( 4 ) subjects, who were exposed to an F I O 2 equivalent to an altitude of approximately 3050 m (10,007 ft).
As a positive relationship exists between ventilation and the oxygen cost of breathing ( 6 ), the role of ventilatory acclimatization and the associated work of breathing should not be overlooked. As ventilation increases at altitude, so too will the work of breathing, and in turn so too will the demand for respiratory muscle blood fl ow ( 6 ) . Post-IMT, however, the work of breathing is likely to be lower and, therefore, so will be the respiratory muscles' demand for cardiac output ( 4 ) . Although, an increase in minute ventilation is the typical response observed at altitude ( 8 , 9 , 13 ) , an increase in exercising S p O 2 without a concomitant increase in exercise minute ventilation has been reported and is consistent with the notion that either red blood cell transit time in the pulmonary capillary bed and/or lung diffusing capacity is enhanced ( 3 ) . Thus, it is not inconceivable that IMT modifi ed the natural hyperventilatory response to altitude, which may have, in turn, reduced respiratory muscle blood fl ow, although this is speculation. In addition, if as previously suggested IMT increases the concentration of inspiratory musculature monocarboxylate transporters, specifi cally MCT1 and MCT4 ( 10 ), the effl ux of lactate and hydrogen ions from fi bers in the respiratory musculature is likely to increase. Accordingly, one may surmise that blood fl ow to the respiratory musculature will be lower as the work of breathing is reduced post-IMT and so too will be the intramuscular acidity driven increase in blood fl ow; although it is hard to envisage how the latter would have a major effect on blood acidity at rest and in turn resting S p O 2 .
Although this study has presented novel data demonstrating that the magnitude of arterial desaturation during hypoxia can be ameliorated following IMT, it is limited by the lack of data relating to the physiological mechanisms underpinning such changes: for logistical purposes it was not possible to collect expired gas samples or undertake cardiac output measures during the sojourn. Rather, this study was a preliminary investigation to determine whether IMT might be useful in reducing the level of arterial desaturation in those subjected to altitude and the approximate altitude range required when at rest. It was not the aim to delineate underpinning mechanisms for any observed change. Nevertheless, there were several limitations to the present study, including the recruitment of a small heterogenous sample, single measurements of S p O 2 and an inability to standardize previous exercise habits of the subjects. In addition, the menstrual cycle stage of the two female climbers was not known. Although the ascent profi les were similar between subjects, it was not possible to standardize ambient temperature. Consequently, it is possible that changes in ambient air temperature (see Table I ) may have affected body temperature and in turn the oxygen-dissociation curve and S p O 2 . However, there is no reason to assume that a reduction in body temperature would have occurred in the IMT group and not the control group. Similarly, the occurrence of acute mountain sickness, the severity of which is associated with arterial oxygen desaturation, was not measured in the current study. Clearly, such limitations should be addressed in future studies.
In conclusion, the aim of this preliminary investigation was to determine whether the level of arterial desaturation occurring during progressive altitude exposure could be attenuated in response to IMT. The fi nding that IMT exerted a protective effect on resting S p O 2 at altitudes of 4880 m and 5550 m is novel. Furthermore, in light of Downey and colleagues ( 4 ) resting observations, it is tempting to speculate that an altitude of between approximately 3050 m and 4880 m is needed before the benefi cial effect of IMT on resting S p O 2 becomes apparent. The physiological mechanisms underpinning the IMT, ALTITUDE, & S P o 2 -LOMAX IMT-mediated alterations in S p O 2 are not well understood and require investigation.
